IRIS Institutional Research Information System - OPENBS Open Archive UniBS

URBINATI, Chiara Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.273
AS - Asia 2.677
EU - Europa 2.666
SA - Sud America 486
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 10.165
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.177
PL - Polonia 1.157
SG - Singapore 1.039
CN - Cina 815
BR - Brasile 410
UA - Ucraina 373
HK - Hong Kong 307
DE - Germania 274
IT - Italia 235
VN - Vietnam 199
FI - Finlandia 136
GB - Regno Unito 129
RU - Federazione Russa 90
TR - Turchia 74
IN - India 73
IE - Irlanda 67
FR - Francia 50
CA - Canada 47
BD - Bangladesh 43
AR - Argentina 35
NL - Olanda 33
MX - Messico 32
ID - Indonesia 31
SE - Svezia 29
ZA - Sudafrica 24
CZ - Repubblica Ceca 23
AT - Austria 20
JP - Giappone 19
MA - Marocco 15
IQ - Iraq 13
EC - Ecuador 12
ES - Italia 12
IL - Israele 11
PK - Pakistan 11
BE - Belgio 10
KE - Kenya 8
LT - Lituania 7
UZ - Uzbekistan 7
CO - Colombia 6
EU - Europa 5
IR - Iran 5
PE - Perù 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
PY - Paraguay 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
PA - Panama 3
AU - Australia 2
BH - Bahrain 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IS - Islanda 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BO - Bolivia 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
TC - Turks e Caicos 1
Totale 10.165
Salva come PNG Salva come JPEG
Città #
Warsaw 1.154
Woodbridge 415
Ashburn 386
Fairfield 382
Singapore 358
Hong Kong 307
Jacksonville 275
Houston 249
Beijing 204
Ann Arbor 194
Cambridge 178
Wilmington 171
Chandler 161
Dallas 161
Seattle 153
New York 140
Princeton 120
Nanjing 97
Los Angeles 88
Dearborn 83
Helsinki 69
Dublin 63
Munich 63
Istanbul 61
Ho Chi Minh City 50
Brescia 46
The Dalles 46
Buffalo 42
Dong Ket 42
Milan 42
San Francisco 39
Hanoi 37
São Paulo 35
Moscow 33
Chicago 32
Shanghai 32
Jinan 31
Nanchang 31
Boardman 30
Lancaster 30
Shenyang 30
Brooklyn 29
Des Moines 26
Redondo Beach 24
San Diego 23
Jiaxing 22
London 22
Tianjin 22
Toronto 22
Changsha 20
Council Bluffs 20
Santa Clara 20
Kunming 18
Nuremberg 18
Phoenix 18
Hebei 17
Jakarta 17
Tokyo 17
Verona 16
Zhengzhou 16
Hangzhou 15
Johannesburg 15
Olomouc 15
Rio de Janeiro 15
Atlanta 14
Poplar 14
Stockholm 14
Turku 14
Florence 13
Groningen 13
Manchester 13
Montreal 13
Chennai 12
Denver 12
Haikou 12
Guangzhou 11
Augusta 10
Brussels 10
Lallio 9
Leawood 9
Mexico City 9
San Mateo 9
Belo Horizonte 8
Boston 8
Dhaka 8
Mumbai 8
Ningbo 8
Querétaro 8
Taizhou 8
Brasília 7
Brno 7
Curitiba 7
Frankfurt am Main 7
Guayaquil 7
Haiphong 7
Lanzhou 7
Nairobi 7
Amsterdam 6
Ankara 6
Beersheba 6
Totale 6.948
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 341
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 296
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 285
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 264
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 262
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 251
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 249
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 213
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 204
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 201
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 198
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 196
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 192
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 182
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 181
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 166
Sialic acid as a target for the development of novel antiangiogenic strategies 164
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 161
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 160
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 155
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 148
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 146
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 139
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 137
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 133
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 132
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 131
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 130
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 130
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 127
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 120
Role of heparan sulfate proteoglycans in HIV-1 Tat-induced transendothelial migration of lymphoid cells 119
Recent Strategic Advances in CFTR Drug Discovery: An Overview 119
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 115
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 111
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF-receptors 110
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 110
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 108
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 106
Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF. 104
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 104
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain 103
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 102
The basic domain in HIV-1 Tat as a target for polysulfated heparin-mimicking extracellular Tat antagonists 101
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 96
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 96
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 94
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 91
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 90
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells 89
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium 88
Thrombospondin/HIV-1 Tat protein interaction: modulation of the biologiocal activity of extracellular Tat 88
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes 86
Thrombospondin-1: the paradigm of antiangiogenic agents endowed with multiple mechanisms of action 84
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium 84
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 84
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein 82
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes 81
Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant Mr 24,000 bFGF 79
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 79
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 77
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing 72
Glycomics and angiogenesis: biological implications and therapeutical exploiting 72
heparan sulfate proteoglycans/HIV-1 Tat interaction: a mechanical and functional bridge between lymphoid and endothelial cells 72
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 71
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 71
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 69
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS 69
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 68
DOES NICOTINAMIDE COMBINES WITH LUMACAFTOR TO IMPROVE F508del-CFTR RESCUE? 68
multidisciplinary approaches to rescue CFTR impairments by drug repositioning 68
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 66
Molecular dynamics simulations to investigate the dynamics and mechanism of action of carbohydrate-based polymers 60
Exploring Alternative BAG3 Targeting Approaches for pediatric medulloblastoma: From small molecules lead optimization to Fragment-Based Drug Discovery 59
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 59
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 58
Computational evaluation of the synergic effect of a small molecule on Lumacaftor F508del-CFTR rescue ability 57
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 55
Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples 53
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 52
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 50
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 50
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 50
implementation of an incremental docking method to study long sugar chains interactions with proteins 47
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 45
A drug repositioning pipeline to evaluate a synergic effect of small molecules on CFTR drugs 43
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 42
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 39
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 35
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 33
Totale 10.327
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021706 0 0 0 0 0 124 42 140 131 79 115 75
2021/2022540 15 108 8 16 5 29 40 40 24 75 44 136
2022/2023438 64 19 26 19 29 125 7 46 63 3 12 25
2023/2024618 36 8 63 35 28 122 17 20 139 16 17 117
2024/20251.763 20 10 7 188 94 109 117 54 139 236 505 284
2025/20262.406 384 516 351 565 392 198 0 0 0 0 0 0
Totale 10.327